CN104173337A - 给药血小板生成素激动剂化合物的方法 - Google Patents
给药血小板生成素激动剂化合物的方法 Download PDFInfo
- Publication number
- CN104173337A CN104173337A CN201410340066.5A CN201410340066A CN104173337A CN 104173337 A CN104173337 A CN 104173337A CN 201410340066 A CN201410340066 A CN 201410340066A CN 104173337 A CN104173337 A CN 104173337A
- Authority
- CN
- China
- Prior art keywords
- compound
- day
- dose
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Abstract
Description
Claims (35)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18214809P | 2009-05-29 | 2009-05-29 | |
US61/182,148 | 2009-05-29 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010800335467A Division CN102458120A (zh) | 2009-05-29 | 2010-05-27 | 给药血小板生成素激动剂化合物的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104173337A true CN104173337A (zh) | 2014-12-03 |
Family
ID=43223061
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010800335467A Pending CN102458120A (zh) | 2009-05-29 | 2010-05-27 | 给药血小板生成素激动剂化合物的方法 |
CN201410340066.5A Pending CN104173337A (zh) | 2009-05-29 | 2010-05-27 | 给药血小板生成素激动剂化合物的方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010800335467A Pending CN102458120A (zh) | 2009-05-29 | 2010-05-27 | 给药血小板生成素激动剂化合物的方法 |
Country Status (20)
Country | Link |
---|---|
US (1) | US8609693B2 (zh) |
EP (2) | EP2434894B1 (zh) |
JP (3) | JP2012528184A (zh) |
KR (1) | KR20120015355A (zh) |
CN (2) | CN102458120A (zh) |
AU (1) | AU2010254046C1 (zh) |
BR (1) | BRPI1014548A2 (zh) |
CA (1) | CA2763768A1 (zh) |
DK (1) | DK3127427T3 (zh) |
EA (2) | EA024557B1 (zh) |
ES (2) | ES2605593T3 (zh) |
HU (1) | HUE049075T2 (zh) |
IL (1) | IL216365A (zh) |
MX (1) | MX2011012668A (zh) |
PL (2) | PL2434894T3 (zh) |
PT (2) | PT3127427T (zh) |
SG (1) | SG176088A1 (zh) |
SI (1) | SI3127427T1 (zh) |
WO (1) | WO2010138656A1 (zh) |
ZA (1) | ZA201108374B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120149749A1 (en) * | 2008-10-16 | 2012-06-14 | Michael Arning | Method of treating thrombocytopenia |
AU2010254046C1 (en) | 2009-05-29 | 2014-03-06 | Novartis Ag | Methods of administration of thrombopoietin agonist compounds |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008136843A1 (en) * | 2007-05-03 | 2008-11-13 | Smithkline Beecham Corporation | Novel pharmaceutical composition |
Family Cites Families (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE193350C (zh) | ||||
US851444A (en) | 1905-11-13 | 1907-04-23 | Agfa Ag | Amido-oxy-sulfonic acid of phenylnaphthimidazol and process of making same. |
GB779880A (en) | 1953-02-27 | 1957-07-24 | Ciba Ltd | Functional derivatives of azo-dyestuffs containing sulphonic acid groups and processfor making them |
US2809963A (en) | 1954-10-26 | 1957-10-15 | Ciba Ltd | Azo-dyestuffs |
DE1046220B (de) | 1956-04-21 | 1958-12-11 | Bayer Ag | Verfahren zur Herstellung von Monoazofarbstoffen und deren Metallkomplexverbindungen |
GB826207A (en) | 1956-07-23 | 1959-12-31 | Bayer Ag | ú´-ú´-dihydroxy-monoazo dyestuffs containing pyrrolidonyl residues and their metal complex compounds |
US2950273A (en) | 1956-11-20 | 1960-08-23 | Agfa Ag | Process for the production of symmetrical and unsymmetrical azo compounds |
US3366619A (en) | 1965-04-09 | 1968-01-30 | Interchem Corp | Disazo pyrazolone pigments |
US4435417A (en) | 1981-02-20 | 1984-03-06 | Gruppo Lepetit S.P.A. | Antiinflammatory 3H-naphtho[1,2-d]imidazoles |
ES8503669A1 (es) | 1982-07-05 | 1985-03-01 | Erba Farmitalia | Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos. |
FR2559483B1 (fr) | 1984-02-10 | 1986-12-05 | Sandoz Sa | Composes heterocycliques contenant des groupes basiques et/ou cationiques, leur preparation et leur utilisation comme colorants |
US4582831A (en) | 1984-11-16 | 1986-04-15 | Pfizer Inc. | Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor |
FI91869C (fi) | 1987-03-18 | 1994-08-25 | Tanabe Seiyaku Co | Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi |
US4880788A (en) | 1987-10-30 | 1989-11-14 | Baylor College Of Medicine | Method for preventing and treating thrombosis |
WO1993017681A1 (en) | 1992-03-02 | 1993-09-16 | Abbott Laboratories | Angiotensin ii receptor antagonists |
IL109570A0 (en) | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
EP0638617A1 (de) | 1993-08-13 | 1995-02-15 | Ciba-Geigy Ag | Pigmentsalze |
EP0661170B1 (en) | 1993-12-28 | 1998-09-02 | Dai Nippon Printing Co., Ltd. | Thermal transfer sheet |
US5482546A (en) | 1994-03-30 | 1996-01-09 | Canon Kabushiki Kaisha | Dye, ink containing the same, and ink-jet recording method and instrument using the ink |
JP2996415B2 (ja) | 1994-03-31 | 1999-12-27 | アムジエン・インコーポレーテツド | 巨核球の成長と分化を刺激するモノpeg化mgdfポリペプチド |
US5760038A (en) | 1995-02-06 | 1998-06-02 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
US5746821A (en) | 1995-02-13 | 1998-05-05 | Engelhard Corporation | Pigment compositions |
CN1315870C (zh) | 1995-06-07 | 2007-05-16 | 葛兰素集团有限公司 | 结合血小板生成素受体的肽和化合物 |
US5622818A (en) | 1995-11-29 | 1997-04-22 | Eastman Kodak Company | Color photographic elements containing yellow colored magenta dye forming masking couplers |
US5669967A (en) | 1996-05-30 | 1997-09-23 | Engelhard Corporation | Pigment compositions |
US5932546A (en) | 1996-10-04 | 1999-08-03 | Glaxo Wellcome Inc. | Peptides and compounds that bind to the thrombopoietin receptor |
SE9701398D0 (sv) | 1997-04-15 | 1997-04-15 | Astra Pharma Prod | Novel compounds |
GB9715830D0 (en) | 1997-07-25 | 1997-10-01 | Basf Ag | Reactive dyes containing piperazine |
WO1999011262A1 (en) | 1997-09-02 | 1999-03-11 | Roche Diagnostics Gmbh | Mpl-receptor ligands, process for their preparation, medicaments containing them and their use for the treatment and prevention of thrombocytopaenia and anaemia |
GB9718913D0 (en) | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
WO1999022733A1 (en) | 1997-10-31 | 1999-05-14 | Smithkline Beecham Corporation | Novel metal complexes |
DE19851389A1 (de) | 1998-11-07 | 2000-05-11 | Dystar Textilfarben Gmbh & Co | Gelbe Farbstoffmischungen von wasserlöslichen faserreaktiven Azofarbstoffen und ihre Verwendung |
GC0000177A (en) | 1998-12-17 | 2006-03-29 | Smithkline Beecham | Thrombopoietin mimetics |
CO5210907A1 (es) | 1999-05-12 | 2002-10-30 | Novartis Ag | Solvatos de pometrozina, insecticidamente activos, composiciones que contienen estos compuestos y metodos tanto para producir dichos compuestos y composiciones como para controlar plagas animales con estas composiciones |
WO2001007423A1 (fr) | 1999-07-26 | 2001-02-01 | Shionogi & Co., Ltd. | Compositions medicamenteuses possedant une activite agoniste de la thrombopoietine |
ES2256038T3 (es) | 1999-09-10 | 2006-07-16 | Smithkline Beecham Corporation | Mimeticos de trombopoyetina. |
EP1223944B1 (en) | 1999-09-24 | 2007-01-03 | SmithKline Beecham Corporation | Thrombopoietin mimetics |
JP2003513965A (ja) | 1999-11-05 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | セミカルバゾン誘導体およびそれらのトロンボポエチン模倣物としての使用 |
EP1104674A1 (de) | 1999-11-10 | 2001-06-06 | Curacyte AG | O,o'-Dihydroxyazofarbstoffe als Bestandteile von Arzneimitteln mit TPO-Agonistischer oder -Synergetischer Wirkung |
TWI284639B (en) | 2000-01-24 | 2007-08-01 | Shionogi & Co | A compound having thrombopoietin receptor agonistic effect |
HUP0001417A2 (hu) | 2000-04-07 | 2002-12-28 | Sanofi-Synthelabo | Gyógyászatilag alkalmazható új sók, eljárás előállításukra és azokat tartalmazó gyógyászati készítmények |
US6214813B1 (en) | 2000-04-07 | 2001-04-10 | Kinetek Pharmaceuticals, Inc. | Pyrazole compounds |
US6436915B1 (en) | 2000-04-07 | 2002-08-20 | Kinetek Pharmaceuticals, Inc. | Pyrazole compounds |
CY2010012I2 (el) * | 2000-05-25 | 2020-05-29 | Novartis Ag | Μιμητικα θρομβοποιητινης |
US7241783B2 (en) | 2000-12-19 | 2007-07-10 | Smithkline Beecham Corporation | Thrombopoietin mimetics |
CA2432800A1 (en) | 2000-12-21 | 2002-07-25 | Smithkline Beecham Corporation | Regulated activation of cell-membrane receptors by metal-chelating agonists |
CN1516696A (zh) | 2001-01-26 | 2004-07-28 | 盐野义制药株式会社 | 对血小板生成素受体具有激动作用的卤素化合物 |
JP4145654B2 (ja) | 2001-01-26 | 2008-09-03 | 塩野義製薬株式会社 | トロンボポエチン受容体アゴニスト作用を有する環状化合物 |
WO2002085343A1 (en) | 2001-03-01 | 2002-10-31 | Smithkline Beecham Corporation | Thrombopoietin mimetics |
JP3927001B2 (ja) | 2001-06-15 | 2007-06-06 | 三菱化学株式会社 | 色素セット、インクセット並びに記録方法 |
RU2332996C2 (ru) | 2001-11-30 | 2008-09-10 | КьюЭлТи Инк. | Производные гидразонпиразола и их применение в качестве лекарственного средства |
US20040176372A1 (en) | 2002-03-01 | 2004-09-09 | Pintex Pharmaceuticals, Inc. | Pin1-modulating compounds and methods of use thereof |
AR040083A1 (es) | 2002-05-22 | 2005-03-16 | Smithkline Beecham Corp | Compuesto bis-(monoetanolamina) del acido 3'-[(2z)-[1-(3,4-dimetilfenil) -1,5-dihidro-3-metil-5-oxo-4h-pirazol-4-iliden] hidrazino] -2'-hidroxi-[1,1'-bifenil]-3-carboxilico, procedimiento para prepararlo, composicion farmaceutica que lo comprende, procedimiento para preparar dicha composicion farmac |
EP1556059A4 (en) | 2002-06-06 | 2010-06-30 | Smithkline Beecham | MIMETICS OF THROMBOPOIETINE |
AU2003268687A1 (en) | 2002-09-30 | 2004-04-19 | Yamanouchi Pharmaceutical Co., Ltd. | Novel salt of 2-acylaminothiazole derivative |
JP2006514951A (ja) | 2002-12-13 | 2006-05-18 | スミスクライン・ビーチャム・コーポレイション | トロンボポエチン模倣物 |
EP2387998A1 (en) | 2003-04-29 | 2011-11-23 | Glaxosmithkline LLC | Methods for treating degenerative diseases/injuries |
TW200526638A (en) | 2003-10-22 | 2005-08-16 | Smithkline Beecham Corp | 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
AU2006287224A1 (en) * | 2005-08-31 | 2007-03-08 | Centocor, Inc. | Host cell lines for production of antibody constant region with enhanced effector function |
CN101384259A (zh) * | 2005-12-22 | 2009-03-11 | 先灵公司 | 作为预防来自心肺外科手术的并发症的凝血酶受体拮抗剂 |
US20090304634A1 (en) | 2006-12-12 | 2009-12-10 | Smithkline Beecham Corporation | Novel Combinations |
UY30915A1 (es) | 2007-02-16 | 2008-09-02 | Smithkline Beecham Corp | Método de tratamiento de canceres |
WO2009151862A1 (en) | 2008-05-15 | 2009-12-17 | Smithkline Beecham Corporation | Method of treatment |
US20120149749A1 (en) | 2008-10-16 | 2012-06-14 | Michael Arning | Method of treating thrombocytopenia |
JP2012526137A (ja) | 2009-05-07 | 2012-10-25 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 血小板減少症を治療する方法 |
AU2010254046C1 (en) | 2009-05-29 | 2014-03-06 | Novartis Ag | Methods of administration of thrombopoietin agonist compounds |
JP6999080B2 (ja) | 2015-04-11 | 2022-02-04 | 株式会社アーティエンス・ラボ | 画像認識システム、画像認識方法、ホログラム記録媒体、ホログラム再生装置および画像撮影装置 |
-
2010
- 2010-05-27 AU AU2010254046A patent/AU2010254046C1/en not_active Ceased
- 2010-05-27 BR BRPI1014548-6A patent/BRPI1014548A2/pt not_active Application Discontinuation
- 2010-05-27 CN CN2010800335467A patent/CN102458120A/zh active Pending
- 2010-05-27 EP EP10781176.2A patent/EP2434894B1/en active Active
- 2010-05-27 US US13/321,577 patent/US8609693B2/en active Active
- 2010-05-27 SI SI201031994T patent/SI3127427T1/sl unknown
- 2010-05-27 SG SG2011084191A patent/SG176088A1/en unknown
- 2010-05-27 EP EP16183711.7A patent/EP3127427B1/en not_active Revoked
- 2010-05-27 CA CA2763768A patent/CA2763768A1/en not_active Abandoned
- 2010-05-27 HU HUE16183711A patent/HUE049075T2/hu unknown
- 2010-05-27 PL PL10781176T patent/PL2434894T3/pl unknown
- 2010-05-27 PL PL16183711T patent/PL3127427T3/pl unknown
- 2010-05-27 ES ES10781176.2T patent/ES2605593T3/es active Active
- 2010-05-27 JP JP2012513237A patent/JP2012528184A/ja not_active Withdrawn
- 2010-05-27 EA EA201171462A patent/EA024557B1/ru not_active IP Right Cessation
- 2010-05-27 PT PT161837117T patent/PT3127427T/pt unknown
- 2010-05-27 MX MX2011012668A patent/MX2011012668A/es active IP Right Grant
- 2010-05-27 PT PT107811762T patent/PT2434894T/pt unknown
- 2010-05-27 ES ES16183711T patent/ES2782898T3/es active Active
- 2010-05-27 DK DK16183711.7T patent/DK3127427T3/da active
- 2010-05-27 KR KR1020117031236A patent/KR20120015355A/ko not_active Application Discontinuation
- 2010-05-27 EA EA201690401A patent/EA201690401A1/ru unknown
- 2010-05-27 WO PCT/US2010/036294 patent/WO2010138656A1/en active Application Filing
- 2010-05-27 CN CN201410340066.5A patent/CN104173337A/zh active Pending
-
2011
- 2011-11-14 IL IL216365A patent/IL216365A/en not_active IP Right Cessation
- 2011-11-15 ZA ZA2011/08374A patent/ZA201108374B/en unknown
-
2015
- 2015-08-10 JP JP2015158039A patent/JP2016020360A/ja not_active Withdrawn
-
2017
- 2017-07-06 JP JP2017132914A patent/JP2017226668A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008136843A1 (en) * | 2007-05-03 | 2008-11-13 | Smithkline Beecham Corporation | Novel pharmaceutical composition |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2862575B1 (en) | Application of piceatannol-3'-o-b-d-glucopyranoside in preparation of medicaments for improving microcirculation block | |
CN104173337A (zh) | 给药血小板生成素激动剂化合物的方法 | |
KR100310121B1 (ko) | 티아조푸린및리바비린을사용하는종양질환의치료방법 | |
CN107137417A (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
EP3692994A1 (en) | Formulation containing a-decarbonized-5 androstane compound for increasing white blood cell and use thereof | |
CN101062066A (zh) | 兽用复方板蓝根注射液及其制备工艺 | |
AU769882B2 (en) | Medicament containing platinum complex compounds and the use thereof | |
CN101185629A (zh) | 一种治疗实体肿瘤的地西他滨缓释剂 | |
CN101181232B (zh) | 一种治疗实体肿瘤的马赛替尼缓释植入剂 | |
CN111558045A (zh) | 一种治疗肺癌的药物组合物 | |
EP0215395A2 (en) | Pharmaceutical composition for retarding and reducing cachexia | |
US7863337B2 (en) | Use of triacontanol in preparation of medicaments for treatment of cancers | |
WO2020226526A1 (en) | Method for increasing cancer patient's haemoglobin level | |
CN100431538C (zh) | 一种抗癌药物组合物及其制备方法 | |
CN104117064A (zh) | 异硫氰酸酯类化合物与激素类药物的联合应用 | |
CN101283996B (zh) | 右旋蛋氨酸在制备防治辐射诱导骨髓抑制药物中的应用 | |
CN109276718A (zh) | 含亚甲蓝注射液的组合封闭液及其应用 | |
CN101219105A (zh) | 一种治疗实体肿瘤的恩曲他滨缓释剂 | |
EA009082B1 (ru) | Агент для улучшения химиотерапии рака | |
CN1615903A (zh) | 蚕用病毒治 | |
CN105030715A (zh) | 抑制乳腺癌肿瘤活性的缓释/控释片剂及制备方法 | |
CN103877114A (zh) | 一种用于胃癌治疗含有卡培他滨的药物组合物 | |
CN101219103A (zh) | 一种治疗实体肿瘤的替匹法尼缓释剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151102 Address after: Basel, Switzerland Applicant after: NOVARTIS AG Address before: Basel, Switzerland Applicant before: NOVA LABORATORIES SDN BHD Effective date of registration: 20151102 Address after: Basel, Switzerland Applicant after: NOVA LABORATORIES SDN BHD Address before: British Meader Sykes Applicant before: Glaxo Group Ltd. Effective date of registration: 20151102 Address after: British Meader Sykes Applicant after: GLAXO Group Ltd. Address before: American Pennsylvania Applicant before: GLAXOSMITHKLINE LLC |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141203 |